Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple Center, Randomised, Parallel Group, Single-blind Clinical Trial, to Assess the Therapeutic Equivalence in Terms of Efficacy and Safety of Test Product (Levosert) and Reference Product (Mirena®) in Patients With Menorrhagia - Phase III (Therapeutic Equivalence).

NCT01695902 is registered in ClinicalTrials.gov with Uteron Pharma S.A. as lead sponsor.

NCT NCT01695902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01695902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple Center, Randomised, Parallel Group, Single-blind Clinical Trial, to Assess the Therapeutic Equivalence in Terms of Efficacy and Safety of Test Product (Levosert) and Reference Product (Mirena®) in Patients With Menorrhagia - Phase III (Therapeutic Equivalence).
Lead sponsor
Uteron Pharma S.A.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
September 30, 2011
Enrollment
280 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding